Lamdong Pharmaceutical JSC (HNX:LDP)

Kronos Bio Balance Sheet

Financials in millions VND. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2019
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2019
Cash & Equivalents	16,589	11,451	16,205	16,619	65,159	28,257
Short-Term Investments	2,224	3,014	2,896	1,788	-	-
Trading Asset Securities	2,452	2,692	1,121	-	-	-
Cash & Short-Term Investments	21,265	17,157	20,222	18,407	65,159	28,257
Cash Growth	15.50%	-15.15%	9.86%	-71.75%	130.59%	172.07%
Accounts Receivable	23,277	27,466	21,535	21,415	23,286	53,300
Other Receivables	1,944	1,207	1,238	10,819	432.72	1,143
Receivables	33,221	36,673	30,773	32,234	23,719	54,443
Inventory	48,911	48,962	37,751	55,919	54,575	94,621
Prepaid Expenses	1,420	2,076	220.82	957.04	284.73	599.99
Other Current Assets	58,672	51,865	51,026	51,458	545.85	958.51
Total Current Assets	163,489	156,733	139,993	158,976	144,283	178,879
Property, Plant & Equipment	41,114	42,555	46,329	55,742	60,718	87,627
Long-Term Investments	-	-	-	-	-	5
Other Intangible Assets	31.18	68.6	229.47	491.92	740.21	4,260
Other Long-Term Assets	9,323	7,800	8,221	13,164	10,180	10,933
Total Assets	213,957	207,157	194,773	228,374	215,921	281,704
Accounts Payable	22,727	31,545	23,549	31,801	13,964	59,830
Accrued Expenses	16,823	16,705	8,887	7,216	3,345	10,864
Short-Term Debt	61,325	55,026	65,368	70,298	29,960	90,679
Current Portion of Long-Term Debt	-	-	591.64	-	-	-
Current Income Taxes Payable	-	172.69	157.19	1,063	7,209	5,959
Current Unearned Revenue	134.18	134.18	-	60	72	720
Other Current Liabilities	4,094	2,520	2,134	3,138	3,933	2,863
Total Current Liabilities	105,103	106,103	100,687	113,574	58,483	170,915
Long-Term Debt	-	-	-	591.64	2,339	9,980
Other Long-Term Liabilities	1,780	1,770	1,720	1,720	1,720	5,519
Total Liabilities	106,883	107,873	102,407	115,886	62,541	186,415
Common Stock	133,382	127,032	127,032	127,032	127,032	78,300
Retained Earnings	-26,307	-27,747	-34,666	-14,543	26,348	16,086
Treasury Stock	-0.32	-0.32	-0.32	-0.32	-0.32	-0.32
Comprehensive Income & Other	-	-	-	-	-	904.23
Shareholders' Equity	107,074	99,284	92,366	112,489	153,380	95,289
Total Liabilities & Equity	213,957	207,157	194,773	228,374	215,921	281,704
Total Debt	61,325	55,026	65,960	70,889	32,299	100,660
Net Cash (Debt)	-40,060	-37,869	-45,738	-52,482	32,860	-72,402
Net Cash Per Share	-3075.16	-2981.05	-3600.54	-4132.07	2586.61	-9245.07
Filing Date Shares Outstanding	13.34	12.7	12.7	12.7	12.7	7.83
Total Common Shares Outstanding	13.34	12.7	12.7	12.7	12.7	7.83
Working Capital	58,386	50,630	39,305	45,402	85,800	7,964
Book Value Per Share	8027.65	7815.75	7271.08	8855.18	12073.06	12167.08
Tangible Book Value	107,043	99,216	92,136	111,997	152,640	91,029
Tangible Book Value Per Share	8025.32	7810.35	7253.02	8816.45	12014.79	11623.13
Buildings	62,604	62,604	62,903	-	-	-
Machinery	63,976	61,717	62,170	-	-	-
Construction In Progress	2,005	2,851	-	690.2	-	-3,102

Source: S&P Global Market Intelligence. Standard template. Financial Sources.